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Abstract. The leukocyte homing receptor (HR), the
endothelial leukocyte adhesion molecule, and gmp140/
platelet activation-dependent granule membrane pro-
tein are members of a family of adhesion molecules,
termed the lectin cell adhesion molecules (LEC-
CAMS) which are unified by a multi-domain structure
containing a lectin motif, an epidermal growth factor-
like (egf) motif, and variable numbers of a comple-
ment binding-like (CB) motif. Previous data have indi-
cated a predominant role for the lectin motif in cell
adhesion directed by the LEC-CAMS, although the egf-
like domain of the HR may also play a potential role
in cell binding. While the role(s) of the CB domains
in the LEC-CAMS is currently not understood, they
have been hypothesized to act as rigid spacers or
stalks for lectin and perhaps, egf domain presentation.
In this paper, we analyze the functional characteristics
of murine HR-IgG chimeras containing the lectin, lec-
tin plus egf, and lectin plus egf plus CB domains. The
Mel 14 mAb, an adhesion blocking antibody which
recognizes a conformational determinant in the
THE lectin cell adhesion molecule (LEC-CAM)' (40)
family currently contains three members; the leuko-
cyte homing receptor (HR) (25, 34, 43), the en-
dothelial leukocyte adhesion molecule (ELAM) (3), and
gmp140/platelet activation dependent granule membrane
protein (PADGEM) (19). The leukocyte HR is found on all
leukocytic cells and appears to be involved with the traf-
ficking of lymphocytes to peripheral lymph node (pln) high
endothelial venules (HEV) (11, 50) as well as the influx of
neutrophils to inflammatory sites (20, 49). ELAM is an en-
dothelial cell surface glycoprotein that is transcriptionally
induced by various mediators of inflammation and which
may be involved in the adhesion of neutrophils, T cells, and
1. Abbreviations used in thispaper: CB, complement binding; DAF, decay
accelerating factor; egf, epidermal growth factor; ELAM, endothelial leu-
kocyte adhesion molecule; HEV, high endothelial venules; HR, homing
receptor; L, lectin; LE, lectin-egf; LEC, lectin-egf-CB; LEC-CAM, lectin
cell adhesion molecule; PADGEM, platelet activation dependent granule
membrane; pln, peripheral lymph node; PPME, polyphosphomannan ester.
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N-terminus of the HR lectin domain, shows a sig-
nificantly decreased affinity for a HR construct which
lacks the CB motifs, consistent with the possibility
that the CB domains are involved with lectin domain
structure. In agreement with this conjecture, HR mu-
tants lacking the CB domains show a profound de-
crease in lectin-specific interaction with the carbohy-
drate polyphosphomannan ester, suggesting that the
changes in Mel 14 affinity for the lectin domain are
reflected in lectin functionality. Various assays inves-
tigating the interactions between the HR deletion mu-
tants and the peripheral lymph node high endothelium,
including cell blocking, immunohistochemical stain-
ing, and radioactively labeled ligand binding, all
showed that removal of the CB domains results in a
lack of HR adhesive function. These results imply that
the CB domains of the HR, and, by analogy, the other
members of the LEC-CAM family, may play important
structural roles involving induction of lectin domain
conformation and resultant functionality.
monocytes to endothelium at certain inflammatory sites (2).
gmp140/PADGEM is a platelet and endothelial cell storage
granule glycoprotein whose cell surface expression is in-
duced by thrombin activation and which allows for neutro-
phil and monocyte adhesion, perhaps to thrombotic sites (4,
13, 21, 27) . All three members of this family of adhesion
molecules contain a multi-domain structure consisting ofan
NH2-terminal type C or calcium-dependent lectin motif (10)
followed by an epidermal growth factorlike (egf) domain and
either two (HR), six (ELAM), or eight to nine (gmpl40/
PADGEM) copies of a motif homologous to the short con-
sensus repeats ofcomplement binding (CB) proteins such as
complement receptor 1, decay accelerating factor (DAF), or
the C3d/Epstein-Barr virus receptor (3, 19, 25, 34, 43).
Genomic structural analysis and chromosomal localization
have revealed that these domains are all encoded by separate
exons and that the LEC-CAM genes all appear to map to a
relativelysmall region of humanand murine chromosomes 1,
adjacent to the regulation of complement activation locus
235which encodes a family ofcomplementbinding proteins con-
taining various numbers of homologous CB domains (9, 29,
43,47).
The relative functional contributions of the protein mofits
found in the LEC-CAMS have been analyzed most directly
for the murine HR and somewhat indirectly for ELAM and
PADGEM/gmp140. Initial data clearly demonstrated the role
ofa lymphocyte surface carbohydrate receptor(s) in lympho-
cyte-pln HEV cell adhesion (40, 41, 42, 51, 52). Subsequent
results demonstrating the identity of this carbohydrate recep-
tor with an antigen recognized by the Mel 14 mAb, an anti-
body which binds to the HR and which blocks lymphocyte-
pin HEV adhesion (12), were consistent with the conclusion
that the HR was a carbohydrate-binding adhesion protein
(14, 17, 52) . These results, thus, indicated a major role for
the HR lectin domain in cell adhesion, presumably by virtue
of its ability to recognize a carbohydrate structure located on
the pin HEV luminal surface. Epitope mapping experiments
confirmed this idea by demonstrating that the Mel 14 adhe-
sion-blocking antibody mapped to a conformational deter-
minant within the lectin domain of the murine HR (6). More
recently, it has been shown that the binding of a recombinant
form of the HR to pin HEV could be completely abolished
by competition with carbohydrates such as fucoidin (48) or
by treatment ofpin endothelium with sialidase (45). In addi-
tion, two recently discovered 50 and 90 kD pin HEV glyco-
protein ligands for the homing receptor have been shown to
have an absolute sialic acid requirement for HR binding,
consistent with the possibility that the carbohydrate recog-
nized by the HR lectin domain contains sialic acid and that
this sugar is required for receptor-ligand interaction (18) .
The complete calcium dependance of cell adhesion directed
by ELAM (16) andgmpl40/PADGEM (13) initially suggested
that the calcium-dependent lectin domains of these adhesion
molecules probably also played a major role in cell adhesion.
Recently, ligands for both ELAM (15, 26, 30, 44, 46) and
gmpl40/PADGEM (8, 22, 28) have been characterized and
have been shown to be related carbohydrates in the Lewis,
family: sialyl Lewisx (ELAM) and lactosyl-N-fucopentose
III (gmpl40/PADGEM) (reviewed in 37). The fact that either
soluble or glycolipid forms of these carbohydrates could
completely inhibit adhesion is consistent with a lectin-car-
bohydrate interaction as a major mediator of cell binding di-
rected by these LEC-CAMS. Interestingly, it appears that
sialic acid is also required for both ELAM and gmpl40/
PADGEM adhesion, consistent with results found for the
homing receptor-ligand interaction. In summary, the bulk of
evidence strongly suggests that the major known interaction
involved with LEC-CAM-mediated cell adhesion involves
the recognition of carbohydrates by the NHZ-terminal lectin
domains found in these glycoproteins.
The potential roles for the egf-like and CB motifs in LEC-
CAM function are less clear-cut . In the case of the murine
HR, examination ofthe LY22 allotypic antibody binding site
indicated that this antibody recognized an epitope contained
within the egf-like domain (35). In addition, this antibody
appeared to block lymphocyte-pin HEV adhesion, appar-
ently without disrupting carbohydrate (polyphosphomannan
ester; PPME) binding, suggesting that the egf-like domain
may also directly participate in cell adhesion. Previous epi-
tope mapping by radio-immunoprecipitation demonstrated
that the reactivity of the Mel 14 antibody for the HR lectin
domain appeared to be abolished when this domain was ex-
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pressed in the absence of the egf-like domain, consistent
with the possibility that the structure of the Mel 14 epitope
was dependent upon the egf-like motif (6) . A similar egfde-
pendence has recently been reported for a mAb directed
against the ELAM lectin domain (46) . The functional role(s)
of the LEC-CAM CB domains is currently not understood.
The exact duplication (at the nucleotide level) of this domain
in the murine genome strongly suggests an important func-
tional requirement for duplicate copies of this domain in the
HR (9). Homology comparisons between human and murine
forms of the HR have shown that the CB motifs are less well
conserved than either the lectin or egf-like domains, al-
though their inter-species degree ofconservation is still rela-
tively high (ti60-80%) when compared to other CB do-
mains (-20- 30%), again implying an important role for
these domains in HR function (5, 32, 43).
In this paper we describe the efficient production of mu-
rine HR-immunoglobulin G chimeras containing the lectin,
lectin plus egf, and lectin plus egf plus CB domains. We have
analyzed these proteins for Mel 14 binding, carbohydrate
recognition, and endothelial cell adhesion. The results es-
tablish a potential role for the CB motifs in HR lectin
function.
Materials andMethods
Construction andPurification ofTruncated
mHR-IgG Chimeras
Cell lines producing either the entire extracellular domain (lectin-egf-CB,
LEC) or truncated forms of the receptor (lectin, L; Lectin-egf, LE) were
produced aspreviously described (6, 48). High level protein production was
accomplished by methotrexate amplification (23, 24). Cells were grown to
large scale in roller bottles, and serum-free cell supernatants were pro-
duced. The various IgG chimeras were purified by protein A sepharose as
previously described (48). Protein concentrations were determined using a
previously described ELISA assay with purified recombinant CD4-IgG as
a standard (7, 48).
AnalysisofMel14 Reactivity
The ability ofthe various IgG chimeras to react with the Mel 14 mAb was
analyzed using a modification of the previously described ELISA format
(48). Purified Mel 14 or anti-human IgG 1 Fc mAb was coated onto the
wells of microtitre plates. Dilutions of serum-free cell supernatants or
purified IgG chimeras were incubated with the plates, the plates were
washed, and the amounts of IgG chimeras captured by either the Mel 14
or anti-human IgG 1 mAbs were determined by reaction ofthe wells with
HRP-conjugated goat polyclonal anti-human Fc antibody.
Analysis ofPPMEReactivity
HR chimera carbohydrate interactions were analyzed using eitherthe previ-
ously published ELISAassay or a modification of it (17, 48) . Inthe modified
procedure, microtitre plates were coated with the yeast cell wall carbohy-
drate PPME by overnight incubation at 4°C of a 10 kg/ml PPME solution
0.2 M Na2P04 (pH 7.6). The wells were blocked with 1% BSA in Dul-
beccds PBS for2 hat 37°C. Protein A sepharose-purified HR-IgG chimeras
were added to the wells and allowed to react for 2 h at room temperature.
The plates were washed and an HRP-conjugated goat anti-human IgG Fc
antibody was reacted with the wells for 30 min at room temperature. The
plates were washed and substrate added as previously described (17, 48).
Analysis ofCell Blocking,
ImmunohistochemicalStaining, andLigand
Precipitationby theIgG Chimeras
Blocking ofmesentericlymphocytebinding to lymph node endothelial cells
and immunohistochemical staining of these cells by the IgG chimeras was
analyzed as previously described (45, 48). Immunoprecipitation of a lymph
236node specific N50-kD glycoprotein with each chimera was done by a
modification of a previously described method (18) . Na 35SO4-labeled mes-
enteric lymph node lysates were precleared with protein A sepharose and
then incubated with 30,ug of each purified chimera or with 100x concen-
trates ofcell culture supernatants from IgGchimera producing lines for 4 h
at 4°C. The complexes were then precipitated with protein A sepharose,
boiled in SDS-beta mercaptoethanol, and resolved on 5-20% acrylamide
gradient gels .
Results
Production ofTruncatedmHR-IgG Chimeras
We previously described the production of large quantities
of aHR-IgG chimeric protein containing the entire extracel-
lular domain of the murine HR (mHR-LEC+IgG) (48) . This
work was extended here to two other previously described
truncated HR-IgG chimeras which contained either the lec-
tin domain alone (mHR-L+IgG) or the lectin plus egf do-
mains (mHR-LE+IgG) (6) (Fig . 1 A) . Human kidney cell
lines producing high levels of each of these glycoproteins
were produced by methotrexate amplification of a co-
transfected dihydrofolate reductase plasmid (23) .The serum-
free supernatants ofthese permanent cell lines were analyzed
using a previously described ELISA assay (40) specific for
the human IgG Fc region, and high level producers were ex-
panded . Material from cell conditioned medium was pas-
saged over protein A sepharose columns, and the resultant
bound material was eluted at low pH and immediately neu-
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tralized . As can be seen in Fig . 1 B, highly purified prepara-
tions ofeach form of the HR could be obtained in thisman-
ner. The purified and tissue culture derived materials were
both capable of forming dimers under nonreducing condi-
tions (data not shown) (40) .
AnalysisofMel 14 Reactivity
Previous work has shown that the Mel 14 mAb appears to
recognize a determinant within the first 53 amino acids ofthe
lectin domain of the murine HR (6) . This also showed that
this recognition appeared to be dependent upon both the CB
and egf domains, since removal of the CB domains appeared
to result in a diminution ofMel 14 reactivity, while removal
of the egf domain resulted in a loss of antibody recognition .
While these results were clearcut, the use of immunoprecipi-
tation to assay the reactivity of each chimera for Mel 14
binding was not quantitative . We have therefore measured
the reactivity of each chimera (L, LE, LEC) here using a
quantitative ELISA-based assay. This assay uses either the
Mel 14mAb or an anti-human IgG 1 FcmAb to capture each
construct, after which the relative amounts captured by each
antibody are analyzed by goat anti-human IgG 1 polyclonal
antiserum binding to the captured antigens .
As shown in Fig . 2 A, all three chimeras appeared to be
captured by the anti-human IgG 1 mAb with similar effi-
ciency. These results suggested that the differentNH2-termi-
nal sequences on these three chimeras appeared to have little
effect on the efficiency of IgG-1 recognition . In contrast to
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Figure 1. Construction and puri-
fication of HR-IgG chimeras. (A)
The structure of the murineHR is
shown with an NH2-terminal sig-
nal sequence (SS), lectin domain,
egf domain, duplicate complement
binding-like domains (CBD),
transmembrane binding domain
(TMD), and cytoplasmic sequence .
The various IgG chimeras includ-
ing the full extracellular domain
(mHR-LEC + IgG), the lectin
plus egf domains (mHR - LE +
IgG), and lectin domain alone
(mHR - L+ IgG) are shown li-
gated to the hinge (H) and CH2
and CH3 domains of the human
IgG 1 heavy chain Fc region. The
cysteine residues (C) in the hinge
region involved with dimer for-
mation are also illustrated . (B)
The three protein A sepharose-
purified HR-IgG chimeras are
shown as visualized by Coomas-
sie staining of a 7.5% polyacryl-
amide-SDS gel .E
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Figure 2. Reactivity of the Mel 14 antibody with various HR-IgG
chimeras. Various quantities of purified chimeras were incubated
in microtitrewellscoated with either an anti-human IgG 1 mAb (A)
or the Mel 14 antibody (B). After incubation, the wells were
washed and incubated with a goat polyclonal anti-human IgG 1
(HRP-conjugated) antibody, after which the wells were washed and
the amount ofboundgoat anti-human antibody measuredbyperoxi-
dase reactivity. Incubation of chimeras in wells containing no cap-
ture antibody gave background signals.
these results, Fig. 2 B illustrates that capture with the Mel
14 antibody showed widely different efficiencies of binding.
Thus, although all three constructs contained the lectin do-
main, the full-length LEC chimera effectively bound to Mel
14 at extremely low chimera concentrations (<100 ng/ml)
whileboth the LE and L forms appeared to give similar lev-
els of binding at much higher chimera concentrations (ti50
ug/ml) . Comparisonofthe Mel 14 recognition of the LE and
L forms showed that the LE form was similarly recognized
at protein levels two- to threefold lower than the L form, con-
sistent with previous immunoprecipitation experiments (6).
Similar results were obtained with unpurified material from
tissue-culture supernatants, suggesting that the purification
procedure did not disrupt Mel 14 antibody recognition. In
summary, these results were consistent with a role for the du-
plicated CB domains in the recognition ofthe Mel 14 epitope
in the HR lectin domain.
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Analysis ofPPME Reactivity
Previous work has demonstrated that both the natural (17) or
IgG chimeric recombinant forms (48) of the HR react with
the yeast cell wall carbohydrate PPME in a specific and ap-
parently lectin-directed manner. Thus, this interaction ap-
peared to be calcium dependent and blocked by the lectin-
binding mAb, Mel 14 (17, 48). To determine the relative
abilities of each chimera to recognize this carbohydrate,
PPME was coated onto microtitre plates and reacted with
each IgG chimera . The amount of bound chimera was then
assayed by incubation with a peroxidase-conjugated poly-
clonal anti-human Fc antibody. As can be seen from Fig. 3
A, the purified LEC chimera recognizedPPME in a calcium-
dependent manner, in agreement with previous experiments
(17, 48). However, the L or LE chimeras showed very limited
reactivity with coated PPME, and this reactivity was often
not calcium dependent. These results suggest that the re-
moval of the CB domains results in a loss of lectin-directed
carbohydrate-binding activity. In addition, they also imply
that the decrease in Mel 14 reactivity was mirrored in a con-
comitant loss of lectin function, consistent with the notion
that the antibody recognizes a conformational determinant
within the lectin domain.
To determine if the L form could react with carbohydrate
under different assay conditions, a second PPME binding as-
say was performed (17) . In this assay, the LEC and L chi-
meric forms were coated onto microtitre plates, reacted with
PPME in solution, after which a polyclonal antibody di-
rected against PPME was used for determining carbohydrate
binding. As can be seen in Fig. 3 B, a very low, but signifi-
cant, level of carbohydrate binding was seen for the L chi-
mera. This binding activity was completely calcium depen-
dent as evidenced by its sensitivity to EGTA. This was in
contrast to the much higher levelofbinding seen for the LEC
form of the molecule. These results were, again, consistent
with the assays shown in Fig. 3 A, but suggested that the
L form alone could bind PPME, albeit at relativelylow levels.
Analysis ofCell Blocking, Immunohistochemical
Staining, and Ligand Interaction
While the PPME binding results were consistent with the
possibility that the removal ofthe CB domains inhibited lec-
tin function, they did not address the interactions between
the HR and any ligand(s) expressed on the endothelial cell
surface. Previously we demonstrated that either the natural
(14) or recombinant forms (49) of the HR could effectively
inhibit endothelial cell binding by lymphocytes in vitro and
neutrophils in vivo (49) . Fig. 4 shows that while the LEC
chimera could effectively inhibit the in vitro binding of
mesenteric lymphocytes to pln HEV, neither the LE nor L
forms of the receptor were effective in inhibiting cell bind-
ing. These results suggested that the profound decrease of
lectin-carbohydrate (PPME) binding function as well as Mel
14 reactivity upon deletion of the CB domains correlated
with the loss of endothelial cell binding and resultant cell
blocking activity.
While the cell blocking experiments implied that HR lack-
ing the CB domains were incapable of interacting with pln
HEV, the relative insensitivity of this assay was a cause for
concern. We, therefore, carried out immunohistochemical
studies using the LEC, LE, and L containing IgG chimeras
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Figure 3. Reactivity of HR-IgG chimeras with immobilized PPME.
(A) The yeast cell wall carbohydrate polyphosphomannan ester
(PPME) was coated onto the wells of microtitre plates, after which
the ability of each HR-IgG chimera to interact with immobilized
carbohydrate was determined by incubation ofeach chimera for 1 h.
Bound chimera was detected by incubation with HRP-conjugated
goat anti-human Fc serum as described in Fig. 2 (B) Purified IgG
chimeras equivalent to one A405 U of either the LEC- or L-IgG
chimeras as measured by anti-Fc ELISA assay were coated onto the
wells of a microtitre plate. Increasing amounts of PPME were in-
cubated for 1.5 h in the wells. In the case of the L-IgG chimera,
either 1 or 20 mM calcium was included. The wells were washed,
and the amount ofbound PPME was measured using a rabbit poly-
clonal anti-PPME antiserum. The specificity ofthe signal obtained
with the LEC or L chimeras was demonstrated by incubating the
reaction in the presence of EGTA to chelate calcium ions.
which allowed for a more sensitive analysis for endothelial
cell binding (48) . This assay uses the IgG chimeras as im-
munohistochemical probes for detecting a HR ligand(s) ex-
pressed on HEV in an approach which is similar to immu-
nohistochemical staining using mAbs (48). LEC chimera
binding has been shown to be calcium dependent, blocked
by Mel 14 and various carbohydrates, and sialidase sensitive,
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Effect of chimaeras on PN binding
120
Figure 4. Ability of HR-IgG chimeras to block lymphocyte-endo-
thelial cell adhesion. Mesenteric lymphocytes were incubated with
frozen sections of peripheral lymph nodes in the presence of PBS
(buffer), each of the chimeras at 1 i~g per frozen section, or purified
spleen cell-derived HR (gp90MEL). Sections were washed and vi-
sualized by microscopy, after which the numbers of lymphocytes
bound to endothelial venules was determined.
implying that the HR lectin domain was intimately involved
with the staining interaction. As can be seen in Fig. 5, the
LEC chimera was clearly effective in staining pln HEV cells,
while both the LE and L containing chimeras showed no
visible HEV staining, even when added at 10-fold higher lev-
els than LEC-IgG. Experiments using the unpurified cell
culture supernatants showed identical results, although the
general background staining was somewhat higher in these
studies (data not shown) . Thus, as with cell blocking studies,
the removal of the CB domains results in truncated mole-
cules that appeared to be incapable of specifically interacting
with HEV.
While the immunohistochemical approach suggested that
truncation of the CB domains completely abolished HEV in-
teractions, it may be argued that a more sensitive analysis
would show some residual HEV ligand(s) binding activity.
Recently, we demonstrated that the LEC chimera could be
used as an immunoprecipitating reagent to bring down a
glycosylated, sulfate-labeled component of -50 kD that was
specific for mesenteric and pin (17) . In addition, a much
more weakly labeled N90-kD component was also occasion-
ally seen . The precipitation of these putative HR ligands is
calcium dependent, inhibited by specific polysaccharides
such as PPME and fucoidin and dependent upon sialylation.
From these results, it was clear that the lectin domain played
a major role in the binding of the HR to these putative
ligands. We, therefore, analyzed the ability of each of the
HR-IgG chimeras to immunoprecipitate material prepared
from mixed mesenteric and pln metabolically labeled with
Na'SSO4 in organ culture. As can be seen from Fig. 6, the
purified LEC chimera specifically immunoprecipitated the
N50-kD glycoprotein, while neither the LE nor L forms
could precipitate this glycoprotein (the N90-kD component
was not seen in these experiments) . Identical results were ob-Figure5 . Staining ofperipheral lymphnode
(pln) high endothelial venules (HEV) with
HR-IgG chimeras. pln were sectioned and
stained with 30 wg per section of each HR
IgG chimera as previously described (36,
38) . The bound chimeras were detected
with a mAbdirected against the human Fc
region conjugated toHRPShownaremicro-
graphs (560x) of HEV stained with the
LEC, LE, and L IgG chimeras .Figure 6. Precipitation analysis of a -50,000 dalton glycoprotein
with the HRIgG chimeras. A mixture of murine peripheral and
mesenteric lymph nodes was sliced and incubated in organ culture
with Na15S04 as previously described (16) . The tissues were de-
tergent extracted and cell-free extracts were incubated with the
LEC, LE, or L IgG chimeras . Bound material was pelleted after
reaction with protein A sepharose beads, and the material was
eluted by boiling in SDS and betamercaptoethanol and analyzed by
7.5% polyacrylamide-SDS gels. Radiolabeled glycoproteins pre-
cipitated with: (A) LEC-IgG chimera ; (B) LEC-IgG chimera in the
presence ofEGTA ; (C) LE-IgG chimera; (D) L-IgG chimera ; (E)
CD4-IgG chimera . Identical results were obtained when 100x
concentrated tissue culture supernatants rather than purified IgG
chimeras were used as the precipitating agents .
tained when tissue culture supernatants were used for the
precipitation experiments . Thus, in agreement with the other
assays performed, the removal ofthe CB domains appears to
have a profoundly negative effect on the function of the HR .
Discussion
The data reported in this paper introduce two novel but com-
plementary concepts about the structure-function relation-
ships of the protein motifs found in the HR . First, the ap-
parent correlation between the loss of Mel 14 antibody
reactivity and lectin domain function is consistent with the
notion that the lectin-localized epitope recognizedby this an-
tibody is an important structural determinant for carbohy-
drate recognition and cell adhesion . The almost complete
correlation between carbohydrate binding and cell adhesive
activities mediated by the HR, together with a large body of
literature on the role of similar lectin domains in carbohy-
drate binding (10), are entirely consistent with this hypothe-
sis, although it is still formally possible that other domains
in theLEC-CAMs also bind carbohydrates . In addition, these
data also support the hypothesis that the CB domains play
an important role in facilitating appropriate lectin domain
structure, as determined byMel 14 antibody recognition and
resultant adhesive functions . While previous discussions
have proposed that theLEC-CAM CB domains may function
as rigid spacer sequences for presentation of the lectin and
egf domains to other cells (36), the data reported here argue
for amore complex role for these motifs in HR function . The
results are, therefore, consistent with a mosaic proteinwhose
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various protein motifs interact with each other to produce a
functionally active carbohydrate recognition domain .
The broad distribution of the CB domain in a number of
proteins suggests that this motif has the potential for a diver-
sity of functions (1, 31) . The use ofthese domains as comple-
ment binding structures has been clearly demonstrated for
members of the regulation of complement activity family
which includes such proteins as complement receptor IA,
C4 binding protein, and decay accelerating factor. Their
function(s) in other members of the complement activation
family, including the serine proteases and terminal compo-
nents, may also be for complement binding, although this is
less clear-cut . Attempts to demonstrate complement binding
activity with recombinant forms of the HR have been unsuc-
cessful (B. Bowen and L . Lasky, unpublished data) . It is in-
teresting that theCB domain is often found juxtaposed to an
egf-like domain, especially in the terminal component fam-
ily, a domain structure which is reminiscent of that found for
theLEC-CAMS, although the functional relevance ofthis as-
sociation is not understood (31) . The role of these domains
in other proteins, such as the interleukin 2 receptor, thyroid
peroxidase, etc., is currently unknown . While it may be ar-
gued that these domains may play structural roles in these
proteins analogous to that found here for the HR, it should
be noted that not only is the overall sequence conservation
between these diverseCB domain motifs weak, there are also
six cysteine residues in the domains found in the LEC-
CAMS while there are only four in the CB domains in other
proteins . This finding argues for a structural role for the
LEC-CAM CB domains which may be specific to these
adhesion molecules .
The wide variety in CB domain repeat numbers is espe-
cially interesting with respect to theLEC-CAM family. If it
is assumed that the presence of the CB domains in ELAM
and gmp140/PADGEM is also critical for lectin structure
and function, then it is puzzling why these proteins have ei-
ther six (ELAM) or eight to nine (gmp140/PADGEM) CB
repeats, respectively, as compared to only two in the HR .
One possibility is that these repeats fulfill multiple roles in
these molecules, including structural, spacer, oligomer for-
mation, and complement binding functions . Indeed, it is
conceivable that one of the CB domains in the HR interacts
with the lectin domain while the other may have a separate
function, such as, for example, the formation of oligomers .
The relative conservation ofCB domain sequences between
the human and murine HRs (ti60-80%) is far greater than
the conservation between the various repeats in the human
LEC-CAM family members (-40%) (5), implying that the
HR CB domains serve functions specific for the HR . It will
therefore be interesting to examine these questions in the fu-
ture by deleting one of the two HR CB domains, and by
replacing one or more of these domains with CB domains
from otherLEC-CAMS . In this way, the relative importance
of CB repeat number as well as primary sequence may be
analyzed .
The quantitative decrease in Mel 14 antibody reactivity
upon deletion ofCB domains is consistent with the previous
observations (6), which argued that the epitope recognized
by the antibody was localized within the lectin domain but
was structurally complex . Indeed, the residual Mel 14 reac-
tivity found here for the L chimeric construct confirms the
previous mapping studies in a more quantitative manner.
24 1Other studies have claimed that the Mel 14 epitope might be
an unusual form of ubiquitin, which can be expressed in the
bacterium E. coli . Given the conformational nature of the
Mel-14 epitope in the HR, it appears unlikely that this struc-
ture can be generated in a bacterial system where it has often
proven difficult to produce appropriately folded mammalian
proteins (11, 33, 38). Thus reactivity to ubiquitin may repre-
sent a fortuitous crossreactivity of the antibody. In the ab-
sence of compelling evidence for the presence of ubiquitin
in the primary sequence of the HR (25), this modification of
the HR is in question. We prefer the interpretation that the
Mel 14 epitope is a structurally complex region of the lectin
domain, whose structure depends on interactions with the
other domains of the molecule.
The complete correlation between the disruption of the
lectin domain as determined by Mel 14 binding and HR func-
tion confirms previous work demonstrating that the lectin
domain plays a major role in cell binding mediated by both
the HR as well as by the other two LEC-CAM family mem-
bers, ELAM and PADGEM/gmpl40 (6, 40, 42, 51, 52) . The
residual carbohydrate-bindingactivity foundfor the L chimera
also could be correlated with the residual Mel 14 antibody
binding of this protein, suggesting that the L domain alone
maintained some low level of carbohydrate-binding confor-
mation. The lack of cell blocking, HEV staining, and ligand
precipitation by this construct, however, suggests that, this
low level of activity is insufficient for appropriate HR recog-
nition of the endothelial cell ligand. The role of the egf do-
main in HR function remains to be elucidated. As was previ-
ously found (6), the consistently greater Mel 14 reactivity
found here for LE vs L containing chimeras suggests that at
leastone role for the egf domain is to somehow influence the
conformation of the lectin domain, although this enhance-
ment is clearly insufficient to allow for efficient carbohydrate
recognition. Similar findings with the ELAM glycoprotein
(46) suggest that this type of interdomain dependence may
be a general aspect of LEC-CAM structure. The findings of
Siegelman et al. (35) implying a direct role for the egf do-
main in cell adhesion are not incompatible with these results.
However, the complete lack of endothelial recognition by the
CB deletion mutant that lacks lectin function suggests that,
ifthe egfdomain does directly interact with a ligand on the
endothelial cell surface, this interaction may not be sufficient
for HR binding. Alternatively, it is possible that the removal
of the CB domains also affects the structure of the egf motif
such that it is no longer functional.
In summary, the work reported here suggests that the CB
domains of the HR and, by analogy, those ofthe other LEC-
CAMS, appear to serve an important role(s) in facilitating
the structure and resultant function of the lectin domain.
Conceivably, these interactions could be intramolecular or
could be because of oligomer formation induced by the CB
domains. The exact CB domain sequence requirements for
this interaction(s) remain to be elucidated, as does the im-
portance of duplicated CB domains. In addition, the possi-
bility that the CB domains are also directly involved in car-
bohydrate binding has not been eliminated by this study, and
this important point must also be examined. It seems clear
that in spiteof the mosaic structure ofthis protein, the lectin
domain does not function as a wholly separate entity but ap-
pears to be dependent upon the presence of the other do-
mains for appropriate structure and function.
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